Medical News

RSS

Cancer Research Technology and The Institute of Cancer Research complete licence with Vernalis

Cancer Research Technology Limited (CRT) and The Institute of Cancer Research announce that Vernalis plc has licensed exclusive worldwide rights to an anti-cancer Hsp90 inhibitor programme.

29 Sep 2004

On-line campaign asks, where does all the breast cancer research money go?

Barbara Ehrenreich and Breast Cancer Action (BCA) have launched an online Flash movie and email campaign that exposes the lack of coordination among more than 30 federal agencies and dozens of private foundations and pharmaceutical companies funding research on breast cancer.

28 Sep 2004

Novel and cost-effective answer to family planning

A color-coded string of beads, called Cycle Beads, are used to help women keep track of the days of their menstrual cycle and see which days they are likely to get pregnant if they had unprotected intercourse.

28 Sep 2004

$1 Million in free cosmetic dental services to survivors of domestic violence

October is National Domestic Violence Awareness Month. More than five million people are battered every year in the United States. Seventy-five percent of women who are in an abusive relationship receive battering to the face and head area, and are not financially able to correct the injuries suffered.

28 Sep 2004

Shoppers misled by minced meat fat content labelling

Britain's Food Standards Agency has found that shoppers are often being misled by minced meat labels which claim that the product contains less fat than it actually does.

28 Sep 2004

West Nile virus detected in blood donor

A Jackson County blood donor is the second person in Oregon to test positive for West Nile virus, according to public health and American Red Cross officials.

28 Sep 2004

Researchers have decoded the genome of Legionella pneumophila, the bacteria responsible for Legionnaires' disease

Researchers at Columbia University Medical Center have decoded the genome of Legionella pneumophila, the bacteria responsible for Legionnaires' disease, and have found a few surprises in the bug's 3,000 genes.

28 Sep 2004

Schools Health Education Unit tracks trends in physical activity

New figures from the Schools Health Education Unit show that since 1991, there has been a decline in the numbers of 12-15 year olds that report playing pool and snooker.

28 Sep 2004

Chiron CEO to appear before the U.S. Senate Special Committee on Aging

Chiron Corporation announced that president and chief executive officer Howard Pien will appear before the U.S. Senate Special Committee on Aging in Washington, D.C., today in a hearing titled, "Combating the Flu: Keeping Seniors Alive."

28 Sep 2004

BMA calls for total ban of smoking in enclosed public places

In his speech today, at the BMA's fringe meeting at the Labour Party Conference in Brighton, BMA Chairman, Mr James Johnson, called upon the Health Secretary, John Reid, to introduce a total ban of smoking in enclosed public places and emphasised that a ban must include pubs and restaurants.

28 Sep 2004

Australian Medical Association backs Labor’s commitment to focus on mental health

Dr Choong-Siew Yong, Psychiatrist and Chair of the AMA’s Public Health and Ethics Committee, today welcomed Labor’s commitment to focus on mental health as a national health priority

28 Sep 2004

Should medical knowledge be extended to enhance the lives of those who are already healthy?

This question and others are addressed in three articles about cosmetic neurology in the September 28 issue of Neurology, the scientific journal of the American Academy of Neurology.

28 Sep 2004

Clusters of genes within human aortas appear to predict risk for atherosclerosis

Duke University Medical Center researchers have identified specific clusters of genes within human aortas that appear to predict with great specificity which patients may be at highest risk for developing atherosclerosis, as well as the severity of the disease.

28 Sep 2004

Guideline evaluates treatments for postherpetic neuralgia

A new guideline from the American Academy of Neurology evaluates treatments for postherpetic neuralgia. The guideline is published in the September 28 issue of Neurology, the scientific journal of the American Academy of Neurology.

28 Sep 2004

Phase II trials of the first second-generation antisense cancer drug to be used in patients soon to be underway

Phase II trials of the first second-generation antisense cancer drug to be used in patients are soon to be underway in the wake of a successful Phase I study, which has demonstrated that the new drug blocks its target gene in exactly the way it is designed to do.

28 Sep 2004

Trial shows which brain cancer patients benefit from temozolomide

An international team of scientists and cancer specialists has identified which patients with the deadly form of brain tumours called glioblastomas are likely to live longer if they are treated with temozolomide, and which patients are likely to get only marginal, if any, benefit.

28 Sep 2004

Researchers reveal potential new role for Glivec/Imatinib

Imatinib – or Glivec as it also known – looks as if it may become an effective treatment for yet another type of cancer.

28 Sep 2004

Arsenic trioxide - invented as a treatment for a rare type of leukaemia

Arsenic trioxide – a highly poisonous substance best known as an effective weed killer or pesticide and notorious for being a favourite ‘weapon’ of choice in murder mystery novels, is being re-invented as a treatment for a rare type of leukaemia.

28 Sep 2004

Microfluidics help lab-on-a-chip development skyrocket

Lab-on-a-chip (LOC) development has skyrocketed in the last couple of years due to constant efforts in harnessing microfluidics and µTAS to improve the LOC design and function. The distinct advantages that they bestow on applications are pushing the commercial potential of LOCs.

28 Sep 2004